Total Payments
$5,665
2024 Payments
$534.70
Companies
35
Transactions
292
Medicare Patients
9,690
Medicare Billing
$808,368
Payment Breakdown by Category
Food & Beverage$5,665 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,665 | 292 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $876.96 | 39 | $0 (2024) |
| Merck Sharp & Dohme LLC | $549.39 | 31 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $429.08 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $427.25 | 25 | $0 (2023) |
| ABBVIE INC. | $322.60 | 15 | $0 (2024) |
| PFIZER INC. | $294.95 | 17 | $0 (2022) |
| Novo Nordisk Inc | $282.76 | 16 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $282.49 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $231.98 | 15 | $0 (2024) |
| Medtronic MiniMed, Inc. | $214.23 | 7 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $534.70 | 25 | ABBVIE INC. ($106.57) |
| 2023 | $479.71 | 24 | ABBVIE INC. ($80.34) |
| 2022 | $509.77 | 25 | Amgen Inc. ($67.14) |
| 2021 | $759.47 | 39 | Bayer HealthCare Pharmaceuticals Inc. ($129.16) |
| 2020 | $457.07 | 23 | Amgen Inc. ($102.09) |
| 2019 | $661.16 | 36 | Amgen Inc. ($114.49) |
| 2018 | $1,017 | 51 | Amgen Inc. ($267.39) |
| 2017 | $1,245 | 69 | Amgen Inc. ($222.37) |
All Payment Transactions
292 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Bone Health | ||||||
| 11/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.05 | General |
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.67 | General |
| Category: Cardiovascular | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: VACCINE | ||||||
| 09/25/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $16.79 | General |
| Category: Coronary | ||||||
| 09/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Gastroenterology | ||||||
| 08/22/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $35.27 | General |
| Category: Medical Device | ||||||
| 08/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.54 | General |
| Category: Cardiovascular | ||||||
| 05/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.70 | General |
| 04/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.52 | General |
| 04/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Diabetes | ||||||
| 03/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Respiratory | ||||||
| 03/04/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Cardiology | ||||||
| 02/27/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Diabetes | ||||||
| 02/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: NEUROSCIENCE | ||||||
| 02/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: Biological | ||||||
| 02/08/2024 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Vaccines | ||||||
| 01/23/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Diabetes | ||||||
| 01/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,632 | 3,609 | $702,015 | $261,007 |
| 2022 | 16 | 2,220 | 3,123 | $551,241 | $194,220 |
| 2021 | 19 | 2,521 | 3,470 | $505,529 | $191,135 |
| 2020 | 20 | 2,317 | 3,171 | $475,669 | $162,006 |
Total Patients
9,690
Total Services
13,373
Medicare Billing
$808,368
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 309 | 768 | $249,600 | $81,820 | 32.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 237 | 237 | $81,291 | $35,845 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 225 | 413 | $92,925 | $32,229 | 34.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 245 | 249 | $62,499 | $23,480 | 37.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 74 | 78 | $51,636 | $21,500 | 41.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 67 | 67 | $42,009 | $12,421 | 29.6% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 60 | 60 | $12,000 | $8,437 | 70.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 161 | 163 | $8,476 | $5,865 | 69.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 229 | 229 | $12,595 | $5,034 | 40.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 57 | 57 | $10,095 | $4,028 | 39.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 266 | 454 | $8,172 | $3,791 | 46.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 225 | 257 | $13,621 | $3,333 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 21 | $9,135 | $3,043 | 33.3% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 60 | 60 | $6,000 | $2,830 | 47.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 75 | 79 | $3,952 | $2,806 | 71.0% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 54 | 80 | $6,240 | $2,433 | 39.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 34 | $4,250 | $1,999 | 47.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 87 | 87 | $4,440 | $1,905 | 42.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 11 | 11 | $4,305 | $1,716 | 39.9% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 21 | 21 | $5,175 | $1,657 | 32.0% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2023 | 19 | 19 | $2,622 | $1,353 | 51.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 23 | $3,197 | $1,083 | 33.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 34 | 34 | $1,870 | $750.72 | 40.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 15 | 15 | $1,545 | $608.25 | 39.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 13 | 24 | $984.00 | $389.28 | 39.6% |
About Dr. Harry Jacob, MD
Dr. Harry Jacob, MD is a Internal Medicine healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346388162.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harry Jacob, MD has received a total of $5,665 in payments from pharmaceutical and medical device companies, with $534.70 received in 2024. These payments were reported across 292 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,665).
As a Medicare-enrolled provider, Jacob has provided services to 9,690 Medicare beneficiaries, totaling 13,373 services with total Medicare billing of $808,368. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location New Hyde Park, NY
- Active Since 02/02/2007
- Last Updated 11/13/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1346388162
Products in Payments
- ENTRESTO (Drug) $404.47
- ELIQUIS (Drug) $365.54
- Prolia (Biological) $300.89
- VRAYLAR (Drug) $293.71
- JARDIANCE (Drug) $285.82
- JANUVIA (Drug) $280.41
- XARELTO (Drug) $248.46
- Repatha (Biological) $222.58
- iPro2 (Device) $214.23
- Corlanor (Drug) $191.40
- Trintellix (Drug) $132.14
- STIOLTO (Drug) $117.00
- Verquvo (Drug) $116.00
- FARXIGA (Drug) $113.68
- VERQUVO (Drug) $93.94
- PRALUENT (Drug) $86.09
- Otezla (Drug) $85.42
- Vascepa (Drug) $83.85
- CHANTIX (Drug) $81.31
- PRALUENT (Biological) $80.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New Hyde Park
Dr. Michael Levine, Md, MD
Internal Medicine — Payments: $394,059
Internal Medicine $394,059
Nikhil Sharma, M.d, M.D
Internal Medicine — Payments: $89,735
Internal Medicine $89,735
Nagashree Seetharamu, Md, MD
Internal Medicine — Payments: $65,767
Internal Medicine $65,767
Dr. Abhinav Agrawal, M.d, M.D
Internal Medicine — Payments: $49,576
Internal Medicine $49,576
Dr. Thomas Mathew, Md, MD
Internal Medicine — Payments: $47,542
Internal Medicine $47,542
Dr. Kennedy Omonuwa, M.d, M.D
Internal Medicine — Payments: $45,556
Internal Medicine $45,556